These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 31722732)

  • 1. Injecting-related health harms and overuse of acidifiers among people who inject heroin and crack cocaine in London: a mixed-methods study.
    Harris M; Scott J; Wright T; Brathwaite R; Ciccarone D; Hope V
    Harm Reduct J; 2019 Nov; 16(1):60. PubMed ID: 31722732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crack-heroin speedball injection and its implications for vein care: qualitative study.
    Rhodes T; Briggs D; Kimber J; Jones S; Holloway G
    Addiction; 2007 Nov; 102(11):1782-90. PubMed ID: 17784900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Navigating environmental constraints to injection preparation: the use of saliva and other alternatives to sterile water among unstably housed PWID in London.
    Harris M; Scott J; Hope V; Wright T; McGowan C; Ciccarone D
    Harm Reduct J; 2020 Apr; 17(1):24. PubMed ID: 32276626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "It's Russian roulette": adulteration, adverse effects and drug use transitions during the 2010/2011 United Kingdom heroin shortage.
    Harris M; Forseth K; Rhodes T
    Int J Drug Policy; 2015 Jan; 26(1):51-8. PubMed ID: 25444768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development, acceptability and feasibility of a personalised, behavioural intervention to prevent bacterial skin and soft tissue infections among people who inject drugs: a mixed-methods Person-Based Approach study.
    Kesten J; Hussey D; Lord C; Roberts L; Bayliss J; Erswell H; Preston A; Telfer M; Scott J; Harris M; Mellon D; Hickman M; MacArthur G; Fisher H
    Harm Reduct J; 2023 Aug; 20(1):114. PubMed ID: 37608267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Care and Prevent': rationale for investigating skin and soft tissue infections and AA amyloidosis among people who inject drugs in London.
    Harris M; Brathwaite R; McGowan CR; Ciccarone D; Gilchrist G; McCusker M; O'Brien K; Dunn J; Scott J; Hope V
    Harm Reduct J; 2018 May; 15(1):23. PubMed ID: 29739408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polydrug Use and HIV Risk Among People Who Inject Heroin in Tijuana, Mexico: A Latent Class Analysis.
    Meacham MC; Rudolph AE; Strathdee SA; Rusch ML; Brouwer KC; Patterson TL; Vera A; Rangel G; Roesch SC
    Subst Use Misuse; 2015; 50(10):1351-9. PubMed ID: 26444185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between injecting illicit drugs into the femoral vein and deep vein thrombosis: A case control study.
    Wright NM; Allgar V; Tompkins CN
    Drug Alcohol Rev; 2016 Sep; 35(5):605-10. PubMed ID: 26644314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The experiences of people who inject drugs of skin and soft tissue infections and harm reduction: A qualitative study.
    Dunleavy K; Hope V; Roy K; Taylor A
    Int J Drug Policy; 2019 Mar; 65():65-72. PubMed ID: 30665085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-care habits among people who inject drugs with skin and soft tissue infections: a qualitative analysis.
    Gilbert AR; Hellman JL; Wilkes MS; Rees VW; Summers PJ
    Harm Reduct J; 2019 Dec; 16(1):69. PubMed ID: 31831010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous access and care: harnessing pragmatics in harm reduction for people who inject drugs.
    Harris M; Rhodes T
    Addiction; 2012 Jun; 107(6):1090-6. PubMed ID: 22151433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and factors associated with chronic venous insufficiency, leg ulceration and deep-vein thrombosis among people who inject drugs in London, UK.
    Doran J; Hope V; Wright T; Scott J; Ciccarone D; Harris M
    Drug Alcohol Rev; 2022 Mar; 41(3):677-685. PubMed ID: 34605086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drawing attention to a neglected injecting-related harm: a systematic review of AA amyloidosis among people who inject drugs.
    Harris M; Brathwaite R; Scott J; Gilchrist G; Ciccarone D; Hope V; McGowan CR
    Addiction; 2018 Oct; 113(10):1790-1801. PubMed ID: 29697879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A qualitative analysis of transitions to heroin injection in Kenya: implications for HIV prevention and harm reduction.
    Guise A; Dimova M; Ndimbii J; Clark P; Rhodes T
    Harm Reduct J; 2015 Sep; 12():27. PubMed ID: 26337729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and severity of abscesses and cellulitis, and their associations with other health outcomes, in a community-based study of people who inject drugs in London, UK.
    Wright T; Hope V; Ciccarone D; Lewer D; Scott J; Harris M
    PLoS One; 2020; 15(7):e0235350. PubMed ID: 32663203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between harm reduction intervention uptake and skin and soft tissue infections among people who inject drugs.
    Dunleavy K; Munro A; Roy K; Hutchinson S; Palmateer N; Knox T; Goldberg D; Taylor A
    Drug Alcohol Depend; 2017 May; 174():91-97. PubMed ID: 28319754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generating trust: Programmatic strategies to reach women who inject drugs with harm reduction services in Dar es Salaam, Tanzania.
    Zamudio-Haas S; Mahenge B; Saleem H; Mbwambo J; Lambdin BH
    Int J Drug Policy; 2016 Apr; 30():43-51. PubMed ID: 26880500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High rates of early HCV reinfection after DAA treatment in people with recent drug use attended at mobile harm reduction units.
    Valencia J; Alvaro-Meca A; Troya J; Cuevas G; Gutiérrez J; Morro A; Alvarez J; Pulido L; Cañamares I; Escobar I; Moreno S; Ryan P
    Int J Drug Policy; 2019 Oct; 72():181-188. PubMed ID: 31253391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug use practices among people who inject drugs in a context of drug market changes: Challenges for optimal coverage of harm reduction programs.
    Roy É; Arruda N; Leclerc P; Morissette C; Blanchette C; Blouin K; Alary M
    Int J Drug Policy; 2017 Jul; 45():18-24. PubMed ID: 28575681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injection into the jugular vein among people who inject drugs in the United Kingdom: Prevalence, associated factors and harms.
    Hope VD; Iversen J; Cullen KJ; Parry JV; Maher L; Nucbe F
    Int J Drug Policy; 2017 Aug; 46():28-33. PubMed ID: 28586700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.